Cinven names McAlpine managing partner in senior reshuffle

McAlpine started his career at EY's Boston and London offices. He then went on to join Royal Bank of Scotland's leveraged finance team.

He joined Cinven in 1996, which promoted him to partner seven years later. His almost 20 years at the global GP have seen him at the head of a number of sizable deals, with a focus on the healthcare industry.

Within that segment, McAlpine coordinated Cinven's work with French oncology diagnostic specialist Sebia, acquired from Montagu Private Equity in a €800m SBO in 2010 and sold back to the firm and Astorg for a 2.4x return four years afterward. He also represented Cinven during the €1.2bn takeover of Parisian clinical test group Labco Diagnostics from 3i in May.

Hugh Langmuir has stepped down from the managing partner role, which he was promoted to in 2009. His appointment at the time, marking the end of Robin Hall's 22-year tenure, preceded the launch of the firm's fifth buyout fund, which closed on €5.3bn in June 2013.

Langmuir had joined Cinven in 1991 and helped set up the GP's Paris office in 2001 – he remained at the helm of the firm's operations in the city until 2006.

Having now been named Cinven executive chairperson, Langmuir will coordinate fundraising for the firm's upcoming sixth vehicle, reportedly targeting a $5.5bn size.

As part of the senior reshuffle, partner Guy Davison will be leaving Cinven after 28 years at the firm. A member of the executive and investment committee, Davison has worked within the UK and Ireland team and focused on consumer assets.

Highlights include UK sports betting chain William Hill, acquired in a £825m buyout in 1999, and ceramic manufacturer CeramTec, carved out of Rockwood Holdings for €1.5bn in 2013.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• People
• Cinven